PharmaShots | Incisive News in 3 Shots

Subscribe Now

MET-Mutated Advanced

Novartis's Capmatinib (INC280) Receives the US FDA's Breakthrough Therapy Designation for MET-Mutated Advanced Non-Small Cell Lung Cancer

Novartis's Capmatinib (INC280) Receives the US FDA's Breakthrough Therapy Designation for MET-Mutated Advanced Non-Small Cell Lung...

September 6, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us